Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research identifying a new high-risk group.

A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and radiation therapies.

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Illuccix® is the first and only PSMA-PET 1 prostate cancer imaging agent to receive full regulatory approval in Brazil. Illuccix®, after radiolabeling with 68 Ga, is a radioactive diagnostic ...

The authors suggest that metastasis is influenced not only by the biologic properties of cancer cells but also ... particularly from prostate and bladder cancers, while metastases from ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

AI-driven tumor mapping with Unfold AI helps doctors more accurately assess prostate cancer size, improving treatment success ...

Illuccix® is the first and only PSMA-PET 1 prostate cancer imaging agent to receive full regulatory approval in Brazil. Illuccix®, after radiolabeling with 68 Ga, is a radioactive diagnostic agent ...

Radiation therapy for prostate cancer can cause short-term side effects such as diarrhea, urine changes, and more. Long-term side effects such as urinary and bowel problems may also occur.

The broadcaster shared her upcoming plans, which include "a double mastectomy" and "getting back in the gym" Omar Vega/Getty Kat Timpf is hopeful amid her breast cancer diagnosis. On Friday ...